Benefits professionals are uniquely positioned to help business owners plan for likely scenarios based on the specific needs and financial health of their business.

If we can play at being race care drivers and airplane pilots, why not take a turn as the nervous stewards of dwindling pots of premium dollars?

Matthew Fiedler wants policymakers to pay more attention to the drug manufacturers.

Medicare Part D spending for 10 selected diabetes drugs surged from $7.7 billion in 2019 to $35.8 billion in 2023, an audit by the U.S. Department of Health and Human Services Office of Inspector General found.